Post Carotid Stenting Cerebral Hyperperfusion: a Preventable Complication

This syndrome, which can be reverted, is also one of the causes of preventable stroke, at least in the context of carotid endarterectomy. At present, there is little information on the incidence of this condition in the context of carotid stenting, which is the purpose of this study, in addition to providing tips to prevent it.

Síndrome de Hiperperfusión cerebral post-angioplastia carotídea: una complicación prevenibleA systematic search resulted in 33 studies with a total 8731 carotid stenting procedures reporting 4.6% hyperperfusion risk (3.1 to 6.8%). Nearly half of hyperperfusion patients later had a stroke (47%), and more than half of strokes resulted fatal or disabling (54%).

 

Symptoms did not appear immediately after procedure, but at average 12 hours after procedure (8 to 36 hour range). This is clearly different form embolic stroke, also diagnosed in the same cath lab.


Read also: Far from a Being a Pun, Malnutrition Tips the Scales in TAVR.


Impaired cerebrovascular reserve was associated to higher risk of post stenting hyperperfusion syndrome (RR 5.18; CI 95% 1.0 to 26.8; p=0.049).

 

If the procedure takes place in the context of a symptomatic patient, the risk of periprocedural stroke is a lot higher ─this we have known for some time now. What we did not know is that evolution with hyperperfusion syndrome involves significantly lower risk of stroke compared to acute patients (RR 0.20; IC 95% 0.07 to 0.59; p=0.001).


Read also: Cost-Effectiveness of Frenestrated or Branched Endoprostheses vs. Open Surgery.


Patients with bilateral carotid stenosis or very critical lesions should be watched closely in the first hours after procedure, and their blood pressure needs to be monitored obsessively.

 

Conclusion

Cerebral hyperperfusion syndrome is relatively frequent and serious in patients undergoing carotid stenting, and it appears in the first hours after procedure, never immediately. We should encourage further research to find out how to treat this phenomenon, and also how to control blood pressure and measure cerebral blood flow.

 

Original title: Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysis.

Reference: Anne E. Huibers et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...